| INTRODUC TI ON
Liver transplant (LT), either from a deceased donor LT (DDLT) or a living donor LT (LDLT), is one of the most invasive gastroenterological surgeries. It has a substantially higher mortality rate than other procedures. Specifically, data from the Scientific Registry of Transplant Recipients (SRTR) 1 and the European Liver Transplant Registry (ELTR) 2,3 showed 6-month and 1-year mortality rates of 10.6%-12.0%
and 12.7%-18.0%, respectively. Additionally, data from the Japanese Liver Transplantation Society showed 1-year mortality rates of 15.3% in 219 DDLT and 16.2% in 7255 LDLT between 1964 and 2013. 4 The
Adult-to-Adult Living Donor Liver Transplantation Study (A2ALL) showed that, in the USA, the 90-day and 1-year mortality rates of LDLT were 13% and 19%, respectively, 5 with morbidity rates of 82.8%
for LDLT and 78.2% for DDLT. 6 The postoperative clinical course after LT should be determined by preoperative/postoperative recipient conditions and donor allograft conditions. Many studies have investigated the preoperative and intraoperative risk factors of recipient-related or allograft-related DDLT and LDLT recipients. 2, 5, [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] However, to our knowledge, a large population study investigating both recipient and donor allograft conditions based on registry data has not been carried out to date. Furthermore, data on intraoperative and postoperative morbidity should dynamically influence the prognosis of LT recipients;
however, as has been reviewed in the literature, morbidity outcomes have been overlooked in current and past studies.
For other gastroenterological surgeries, risk models of mortalities for eight procedures, including hepatectomy 20 and Pancreatoduodenectomy, 21 have been developed using preoperatively determined variables, based on nationwide clinical data registries, the National Clinical Database (NCD), along with implemented feedback reports by the participants. 22 In contrast, the Japanese Liver Transplantation Society (JLTS) accumulated precise demographic data of all LT recipients and living donors in Japan from 2012. The data included graft weight and ABO compatibility, 4 which is information not included in the NCD database. However, as opposed to the NCD database, the JLTS database did not record postoperative morbidities. Integration of two nationwide databases of LT recipients in a single registry may make up for these deficits.
In the present study, we used an integrated nationwide database to develop risk models of postoperative morbidity and mortality in LT recipients. We included preoperative variables as well as operative and procedural variables, such as estimated blood loss or operative duration. Furthermore, we developed real-time risk models with postoperative morbidities, such as re-intubation and sepsis, so that each time point of pre-and postoperative management could be precisely evaluated for mortality risk. Results were subsequently validated with an independent validation cohort.
| MATERIAL S AND ME THODS
This study was approved by the project committee of the JLTS, the ethics committee of the Japan Society of Transplantation (JST), and the institutional review board of Osaka General Medical Center, Osaka, Japan.
| Data collection and integration of two nationwide registry data: NCD and JLTS databases
All LT recipient surgeries, as well as living or cadaveric donor surgeries, that were registered in the NCD and/or JLTS databases between 2012 and 2015, were included as a derivation cohort. Surgeries registered in 2016 were included in this study as an independent dataset. NCD included 60 preoperative, 18 intraoperative, and 31
postoperative variables. The latter included morbidities within 30 days after surgery in both live, partial LDLT, and DDLT recipients.
However, the NCD did not include the following variables: donor graft weight; ABO compatibility (identical, compatible, and incompatible); re-transplant; and primary diagnosis. On the contrary, the JLTS registry did include these data, as well as donor graft weight from 2012. In the present study, we combined these two national registries and ensured protection of personal information by nonlinkable anonymization.
We The new integrated database included all data from the NCD.
The JLTS database included data on: primary diagnosis of the recipients; ABO blood type compatibility; re-transplant (history of past LT); deceased/living donor; and graft volume. 4 In the present study, we used data from the integrated database, which included the following: 13 categorical and 13 continuous preoperative variables; six continuous intraoperative variables (Table 1 and Table S1 ); and 27 categorical variables on postoperative morbidity (Table 2 ) and mortality. Preoperative categorical variables included activities of daily living (ADL), which was defined as functional status either totally, partially dependent or independent. The former two categories (totally and partially dependent ADL) were considered as one category of "ADL with any assistance." 22 Continuous variables were divided into binary data. The best cutoff value was determined based on the least P-value in the Pearson's chi-squared test between the binary variable and death (Tables S1 and S3 
| Endpoints
Analysis endpoints were as follows: postoperative morbidities and mortality within 30 days for C1 and C2; mortality for C1, C2, and C3.
Postoperative mortality included both in-hospital deaths and deaths within 30 days post-surgery.
| Statistical analysis and real-time risk model
Statistical analysis was carried out using two software programs Inc., Cary, NC, USA), and α was established a priori at 5%. An independent validation dataset was used to evaluate the predictive accuracy of the risk-adjustment model by using receiver operator characteristic (ROC) curves, area under the curve (AUC), and calibration plots ( Figure S1 ).
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Continuous and categorical variables with three or more levels were treated as binary variables with cutoff points being de- To create the real-time risk models, with the exception of the risk model for mortality using C3 variables, all variables that significantly correlated with death at a significance level (alpha) of 0.10 were subjected to multivariate logistic regression analysis. Among four intraoperative variables with a P-value <0.10 ( Table 1 and Table S1 ), operative time and estimated blood loss were selected as candidate independent variables for logistic regression analysis. The remaining two variables (total volume of infusion during surgery and number of fresh frozen plasma units given intraoperatively) were not selected as candidate independent variables because they were both highly correlated (P < 0.0001) with the former two variables. With regard to the risk model for mortality using C3 variables, all C2 variables with a P-value <0.10, postoperative morbidity variables with a P-value <0.10, those with an incidence of >5% in all patients, and those with >20% conditional incidence of mortality were subjected to multivariate logistic analysis.
Logistic regression models were constructed using backward stepwise selection of predictors, with a criterion of P-value <0.05.
As a measure of model discrimination, C-statistics (area under the ROC curve, AUC) were calculated for each risk model using an independent validation cohort. Calibration plots were drawn to visually examine the calibration of each model. Subjects were divided into 10 bins using threshold deciles of predicted risks. reported that MELD score and RGW/SLV were independent risk factors for small-for-size graft failure in LDLT. To evaluate the fitting of our real-time risk model, we compared our results with those of the above-mentioned studies, in particular the data on adult-to-adult LDLT. In order to compensate for the differences in calibrations between the model developed in this study and those of previous studies, we used recalibrated versions of previous univariate logistic models obtained using previous risk models as a single independent variable.
| Validation analyses in the subgroups of deceased versus living donors and adult versus pediatric recipients
Postoperative morbidities and mortality could be influenced by neoplastic diseases (n = 241); acute liver failure (n = 128); or retransplant for graft failure (n = 49; Table 4 ). Overall mortality rate was 8.4% (n = 124). Highest mortality rates were seen in recipients with a primary diagnosis of hepatocellular disease, neoplastic disease, acute liver failure, vascular disease, and re-transplantation (23.4%), whereas lower mortality rates were seen in patients with cholestatic and metabolic disease (Table S3) . Distributions of allograft lobes or segments in the derivation cohort can be observed in Table 5 . In LDLT, most of the adult recipients received the right (n = 449, 48.4%) or the left lobe (n = 450, 48.5%), whereas the majority of the pediatric recipients received the left lateral section (n = 272, 69.4%).
| RE SULTS

| Risk profiles and study population data
Preoperative characteristics of patients in the derivation cohort are shown in Tables 1 and 3 . Although ABO blood type compatibility and deceased/living donor were not associated with mortality, the majority of the other pre-and intraoperative characteristics were linked to mortality (Table 3) . Incidence of postoperative morbidities and mortality rates in the derivation cohort is reported in syndrome (SIRS) and septic shock; and hyperbilirubinemia (>10 mg/ dL). These variables were included in the C3 set of candidate independent variables.
| Risk calculator models based on preoperative risk factors for morbidities and mortality: the C1 model
Risk models that used C1 categorical variables were created separately for morbidities and mortality with independent risk factors ( Table 6 ). AUC of the risk calculator model for morbidities using the validation cohort ranged from 0.56 to 0.78, and that for mortality was 0.74 (95% CI: 0.63-0.82). Independent risk factors for morbidity and mortality were slightly different: ADL with any assistance; preoperative recipient's weight ≥75 kg; activated partial thromboplastin time >40 seconds; re-transplantation (preoperative recipient-related variables); and RGW/SLV and donor age (donor-related variables) were the independent risk factors for mortality. 
| Comparison between risk models developed in previous studies and those in the current study
| Risk calculator models using preoperative and intraoperative risk factors for morbidities and mortality: the C2 model
Risk models based on the C2 variables were created separately for morbidities and mortality using independent risk factors ( Table 6 ). 
TA B L E 6 Multivariate logistic regression analyses of pre-, intra-, and postoperative factors for morbidities and mortality after liver transplant
Postoperative mortality Preoperative variables (C1) Preoperative and intraoperative variables (C2)
Pre-, intra-, and postoperative variables (C3)
OR (95% CI)
Pvalue OR (95% CI)
Pvalue
Constant (β0) 
OR (95% CI)
Pvalue OR (95% CI)
Pvalue
Unplanned reoperation within 30 d for intra-abdominal bleeding Unplanned reoperation within 30 d for reasons other than intra-abdominal bleeding Preoperative variables (C1) Preoperative and intraoperative variables (C2) Preoperative variables (C1) Preoperative and intraoperative variables (C2) OR (95% CI)
Pvalue OR (95% CI)
Pvalue
Bleeding disorders prior to surgery Preoperative systemic sepsis 
Unplanned reoperation within 30 d for intra-abdominal bleeding Unplanned reoperation within 30 d for reasons other than intra-abdominal bleeding Preoperative variables (C1) Preoperative and intraoperative variables (C2) Preoperative variables (C1) Preoperative and intraoperative variables (C2) OR (95% CI)
Pvalue OR (95% CI)
Pvalue
OR (95% CI)
Pvalue OR (95% CI)
Pvalue
Pvalue OR (95% CI)
Pvalue
Preoperative dialysis <14 d
Acute renal failure (within 24 h) Steroid use for chronic condition (history) 
| D ISCUSS I ON
In the present study, we used a combination of two Japanese nationwide databases to develop risk models of postoperative morbidity and mortality in LT recipients. To this end, we used three variable categories (C1, C2, and C3) for mortality and two variable categories Several studies used either single-center analysis 8, 9 or registry data 2,7 to focus on the C1 risk model for mortality after LT. Importantly, although previous risk factor analyses included the MELD score as a preoperative predictor using C1 variables, 8, 9, [11] [12] [13] 15, 25, 28, 29 in the present study, similar to a previous meta-analysis, 30 it was not an Data are expressed by odds ratio (95% confidence interval) and P-value.
a Units of odds ratios for continuous variables are denoted in parentheses.
TA B L E 6 (Continued) independent risk factor. Observation of a significantly improved AUC of the C1 risk calculator model for mortality versus the previously reported equations from single-center analyses 8, 9 indicates an effectiveness of these novel risk calculator models. In another words, compared with such risk models, our risk calculator was based on Japanese nationwide registry data and was more informative in terms of the data on the AUC.
Among the preoperative (C1) variables, re-transplant (odds ratio, 2.55) and patients with ADL with any assistance (input to the NCD registry based on data collected prior to LT) (odds ratio, 2.17) had the highest risk for mortality using C1 variables. The other independent risk factors for mortality included donor age, allograft volume ratio to SLV, which were well-known risk factors for allograft failure in LDLT. 8, 9, 11, 25 One of the possible explanations for missing MELD score as an independent preoperative (C1) risk factor for mortality was that combination of other variables, including ADL and re-transplant, was more important than MELD score.
Notably, real-time risk model was more accurate in the C3 model factors. This observation indicates that these morbidities were more important among all variables, and that they were directly associated with mortality compared with preoperative variables. The latter were indirectly associated with mortality through postoperative morbidities.
Similar to previous findings from a single-center study, 31 our results confirmed that hyperbilirubinemia following LT was a highly accurate marker for mortality, with an odds ratio of 2.24. Additional factors such as ADL with any assistance, preoperative weight ≥75 kg, RGW/SLV, and donor age were indirectly associated with mortality F I G U R E 2 Schematic concept of "real-time" risk calculator models of postoperative morbidities and mortality. "Real-time" risk models provide the expected risk of morbidities and mortality at any time point from pre-, intra-, and postoperative periods within 30 d after the surgery. We used three variable categories (C1, C2, and C3) for mortality and two variable categories (C1 and C2) for 10 postoperative morbidities. C1, preoperative variables; C2, C1 + intraoperative variables; C3, C2 + postoperative morbidities by variables such as hyperbilirubinemia, prolonged ventilation, coma, renal dysfunction, and postoperative systemic sepsis as shown in Table 6 .
DDLT and LDLT ratios are quite different in Japan versus in other countries. In the present study, similar to a previous report, 4 LDLT was more common (89.6%) in the derivation cohort. However, mortality risk was similar among donor types (P-value = 0.973, data not shown). Types of recipient, either adult versus pediatric recipients, were also not independent risk factors for mortality and morbidities. Therefore, these variables were not included in the real-time risk models. However, we further evaluated the accuracy of the risk models in these subgroups of DDLT versus LDLT and adult versus pediatric recipients using 2016 data, showing that our risk models, although they did not discriminate between these types of donors and recipients, could accurately determine the risks of each subgroup.
Although marginal allograft, such as severe steatosis and extended ischemia time, might influence the postoperative morbidity and mortality in deceased donors, 18, 29 in the present study, we used exclusively donor age and graft volume as donor variables. In the majority of cases, allograft qualities such as cold ischemic time, steatosis, and fibrosis were sufficient and not marginal as a result of the nature of LDLT, which represented the majority of LT in this cohort. In
Western countries where DDLT is the main procedure, our risk calculator would not be valid for LT recipients in its current form. However, the results of this study that postoperative morbidities and mortality were able to be accurately calculated using the simple data sets of C1, C2, and C3 variables, as well as the concept of these real-time risk models, could still be applicable, and regional real-time risk models could be developed in a similar way using, for example, big national registry data.
National registry data, which we used, were developed following the best field practices in each hospital. Importantly, hospital factors, such as high-or low-volume center, were not included in this study.
A limitation of the present study was that our compiled database contained only in-hospital morbidities and 30-day mortality postsurgery. As a consequence, the risk of mortality from morbidities beyond 30 days post-surgery could not be evaluated using our database. Another limitation was that we did not include the exact time points of the occurrence of morbidities and their severities, as well as the specific variables for LT such as biliary/vascular complications.
Unfortunately, as these variables were not available in the NCD and JLTS databases, we could not evaluate them in the current study. An additional limitation was that important variables in DDLT such as donor status, cause of death, cold ischemia time, or extent of steatosis of allograft were not included in this analysis. Using these specific variables with more DDLT cases will allow further refinement to the risk calculators for DDLT in the future. Another additional limitation was that in this study, we did not take into consideration the institutional disparities of surgical outcomes. This should be one of the next aspects to be evaluated for an accurate prediction of postoperative morbidities and mortality. Furthermore, our sample size was small compared with a previous registry-based study. 2 Nevertheless, an important advantage of the present study was the use of recent national data and the exclusion of results from the earlier periods when LT was evolving and developing.
In conclusion, we established real-time risk models of postoperative morbidities and mortality for LT recipients at various perioperative time points using the combined data of the NCD and JLTS databases in Japan. Risk models and real-time risk calculators are novel and viable tools aimed at improving the postoperative outcomes of LT recipients. These real-time risk models could likewise be applicable and useful for several additional surgical procedures, which maintain certain risks for morbidity and mortality. 
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